DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Schmoll HJ et al.
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
J Clin Oncol 2007;
25 (01) 102-109
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.